November 2026 Newsletter
Sponsored Research
Iris Titos-Vivancos, PhD, assistant professor of Biochemistry and Molecular Genetics and Psychiatry and Behavioral Sciences, received the Avenir Award from the National Institute of Drug Abuse at the National Institutes of Health. The Avenir Award provides $1.5 million and targets early-stage investigators that propose innovative studies in the field of substance use disorder. Titos-Vivancos believes that this research will provide new insights into the molecular and epigenetic mechanisms that regulate dopamine activity and contribute to the development of substance use disorder.
What are the aims of the project?
The main aim of this project is to identify how neuropeptides regulate dopamine activity in the brain and how these interactions contribute to substance use disorder (SUD). Although dopamine signaling is strongly associated with addiction, targeting dopamine directly can cause significant side effects because dopamine also regulates essential functions such as sleep, movement and motivation. We aim to identify specific peptidergic receptors expressed in dopaminergic neurons and investigate how their activation influences neuronal function and addiction-related behaviors. To do that we are using Drosophila as a model system.
What are your next steps?
Our next steps will focus on systematically identifying and characterizing peptidergic receptors expressed in dopaminergic neurons in Drosophila. We will systematically characterize these receptors, determine their localization within the brain's reward system and investigate the intracellular signaling pathways they activate. In particular, we will examine how these pathways influence epigenetic modifications and gene expression programs in dopaminergic neurons.
What do you hope will come out of this funded research?
By combining molecular, genetic and behavioral approaches, we hope to establish a comprehensive understanding of how peptidergic signaling regulates dopamine function in the context of addiction. We hope this research will provide new insights into the molecular and epigenetic mechanisms that regulate dopamine activity and contribute to the development of substance use disorder. Understanding these mechanisms could reveal ways to selectively regulate dopamine activity without interfering with its many other essential functions. In the long term, this research could contribute to the development of new approaches for the prevention and treatment of addiction, addressing an important unmet medical need.